0002087846-26-000003.txt : 20260928 0002087846-26-000003.hdr.sgml : 20260928 20260925201335 ACCESSION NUMBER: 0002087846-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260928 DATE AS OF CHANGE: 20260925 EFFECTIVENESS DATE: 20260928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vertical Longevity Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0002087846 ORGANIZATION NAME: EIN: 334492012 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598960 FILM NUMBER: 261411637 BUSINESS ADDRESS: STREET 1: 17 RINCON CITY: IRVINE STATE: CA ZIP: 92620 BUSINESS PHONE: 7608558072 MAIL ADDRESS: STREET 1: 17 RINCON CITY: IRVINE STATE: CA ZIP: 92620 D 1 primary_doc.xml X0708 D LIVE 0002087846 Vertical Longevity Pharmaceuticals, Inc. 17 RINCON IRVINE CA CALIFORNIA 92620 7608558072 DELAWARE None None Corporation true 2024 David Philip Scieszka 17 Rincon Irvine CA CALIFORNIA 92620 Executive Officer Biotechnology No Revenues 06b false 2025-11-04 false true true false 0 110000 110000 0 false 5 0 0 0 false Vertical Longevity Pharmaceuticals, Inc. David Scieszka David Scieszka CEO 2026-09-25